Ticker

Analyst Price Targets — MPT

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
February 3, 2026 1:47 pmMaxim Group$8.00$5.20TheFly Medical Properties Trust initiated with a Buy at Maxim
November 25, 2025 7:41 pmWells Fargo$5.00$5.65TheFly Medical Properties Trust price target raised to $5 from $4.50 at Wells Fargo
March 11, 2025 11:19 pmNate CrossettBNP Paribas$9.00$5.70TheFly Medical Properties Trust upgraded to Outperform from Neutral at Exane BNP Paribas
September 13, 2024 6:54 amMichael LewisTruist Financial$6.00$5.60StreetInsider Medical Properties Trust (MPW) PT Raised to $6 at Truist Securities
September 13, 2024 4:59 amDavid TotiColliers Securities$6.50$5.60StreetInsider Colliers Securities Upgrades Medical Properties Trust (MPW) to Buy
September 12, 2024 7:55 amVikram MalhotraMizuho Securities$7.00$5.65StreetInsider Mizuho Reiterates Neutral Rating on Medical Properties Trust (MPW)
August 2, 2024 7:59 amMichael LewisTruist Financial$8.00$4.63Benzinga Wall Street's Most Accurate Analysts Give Their Take On 3 Real Estate Stocks With Over 7% Dividend Yields
August 2, 2024 7:59 amDori KestenWells Fargo$7.50$4.63Benzinga Wall Street's Most Accurate Analysts Give Their Take On 3 Real Estate Stocks With Over 7% Dividend Yields
July 1, 2024 4:17 pmNate CrossettBNP Paribas$4.00$4.09TheFly Medical Properties Trust downgraded to Neutral from Outperform at Exane BNP Paribas
May 29, 2024 4:13 pmMichael LewisTruist Financial$5.00$4.98StreetInsider Medical Properties Trust (MPW) PT Raised to $5 at Truist Securities

Latest News for MPT

Medical Properties Trust: The Second-Most Shorted REIT And Its 7.2% Dividend Yield

Medical Properties Trust, Inc. faces elevated short interest at 23.25%, despite dual beats for its fiscal 2025 fourth quarter. MPT reported fourth-quarter revenue of $270.34 million, up 16.6% over its year-ago comp, with FFO of $0.18 covering the dividend by 200%. The REIT faces material debt maturities over the next two years, with $1.23 billion due in 2026 and $1.60 billion due next year.

Seeking Alpha • Apr 15, 2026
Bain Capital and Evergreen Medical Properties Acquire Portfolio of Six Medical Outpatient Facilities in Atlanta Metropolitan Area

ATLANTA & BOSTON--(BUSINESS WIRE)--Bain Capital's Real Estate team ("Bain Capital") and Evergreen Medical Properties (“Evergreen”) today announced the acquisition of a medical outpatient building portfolio consisting of six assets totaling approximately 665,000 square feet in the Atlanta metropolitan area. The private, off-market purchase was completed via a partnership between Bain Capital and Evergreen that…

Business Wire • Apr 9, 2026
Mousetraps: 9 High-Yield REITs With Risky Dividends

High-yield 'mousetrap' REITs consistently underperform, with significant risk of dividend cuts and capital loss, as evidenced by recent 12-month returns lagging VNQ by over 1,000 bps. Dividend Safety scores are critical; REITs rated F face a 40% chance of a cut within 12 months, often resulting in sharp share price declines. Key danger signals include high payout ratios, weak revenues, and heavy debt loads.

Seeking Alpha • Apr 8, 2026
Medical Properties Trust: New Tenant Risk Meets Promising Recovery Cadence - Contrarian Buy

Medical Properties Trust faces new risks from HSA, a tenant that comprises 7.2% of the FQ4'25 revenues, with the tenant's ongoing litigation contributing to the REIT's recent selloff. Despite the uncertain macroeconomic risks, the REIT's improving portfolio/balance sheet performance signals resilience, aided by the secure AFFO payout ratio at 50%. H2'26 may also bring forth notably improved top/bottom lines once…

Seeking Alpha • Apr 7, 2026
Franklin Street Properties (NYSE:FSP) vs. Medical Properties Trust (NYSE:MPT) Financial Survey

Medical Properties Trust (NYSE: MPT - Get Free Report) and Franklin Street Properties (NYSE: FSP - Get Free Report) are both real estate companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, profitability, risk, analyst recommendations and dividends. Profitability This table compares Medical

Defense World • Mar 25, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for MPT.

No House trades found for MPT.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top